Q3 2017 13F Holders as of 9/30/2017
-
Type / Class
-
Equity / COM
-
Number of holders
-
681
-
Total 13F shares, excl. options
-
91.5M
-
Shares change
-
-2.18M
-
Total reported value, excl. options
-
$13.8B
-
Value change
-
-$333M
-
Put/Call ratio
-
0.76
-
Number of buys
-
268
-
Number of sells
-
-328
-
Price
-
$150.97
Significant Holders of Labcorp Hldgs Inc. - COM (LH) as of Q3 2017
760 filings reported holding LH - Labcorp Hldgs Inc. - COM as of Q3 2017.
Labcorp Hldgs Inc. - COM (LH) has 681 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 91.5M shares
.
Largest 10 shareholders include VANGUARD GROUP INC (10.4M shares), BlackRock Inc. (7.81M shares), Boston Partners (4.62M shares), STATE STREET CORP (4.43M shares), GLENVIEW CAPITAL MANAGEMENT, LLC (2.91M shares), NORDEA INVESTMENT MANAGEMENT AB (2.34M shares), UBS ASSET MANAGEMENT AMERICAS INC (1.68M shares), GOLDMAN SACHS GROUP INC (1.63M shares), IRIDIAN ASSET MANAGEMENT LLC/CT (1.58M shares), and HealthCor Management, L.P. (1.57M shares).
This table shows the top 681 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.